WMIF MAIN SITE

2024 COMING SOON

Past Forum 2023

Summary

The ninth annual World Medical Innovation Forum was at a new venue, Westin Seaport Boston.

This year, we gathered to discuss the extraordinary opportunities in CNS/Brain Health, Oncology, Inflammation & Immunology and the profound impact they will have on medicine. In more than thirty sessions over the course of three days, Mass General Brigham’s Harvard faculty, industry experts and leading investors and entrepreneurs explored the technologies and challenges as we continue to bring life-changing breakthroughs to our patients and millions around the world.

The World Medical Innovation Forum was established to reaffirm the importance of collaborative innovation—academia, industry and government working together to create solutions for medicine’s great challenges. Our goal is to provide actionable insights for Forum participants. We are grateful to the nearly 200 senior executives, investors, Harvard clinicians and investigators who shared their perspectives as speakers.

 

2023 Resources

Program Book Recaps & Summaries

Disruptive Dozen

Watch Now Press Release

Speakers

Managing Director, Global Research, BofA Securities

Frank Wilkens Jr and Family Endowed Scholar in AD Research, MGH; – Assistant Professor of Neurology, HMS

Atlantic Charter Director of the Discovery Center for Musculoskeletal Recovery, Schoen Adams Research Institute, Spaulding Rehabilitation Hospital; – Faculty, HMS

Acting Chief Academic Officer, Mass General Brigham; – Professor of Medicine, HMS

Lancer Endowed Chair of Dermatology; – Director, Wellman Center for Photomedicine, MGH; – Professor of Dermatology, HMS

Chief Digital Health Physician, MITRE

Director, Alzheimer’s Clinical & Translational Research Unit, – Translational Neurology Head & Managing Director, Interdisciplinary Brain Center, MGH; – Professor of Neurology, HMS

Associate Bioengineer, BWH; – Associate Professor of Medicine, HMS

Vice President Clinical Research, BWH; – Professor, HMS

CFO, 2seventy bio

CEO, Orna Therapeutics

Physician, BWH; – Associate Professor, HMS

Neurologist/ALS Clinical Researcher, MGH; – Associate Professor, HMS

Managing Director, Healthcare Investment Banking, BofA Securities

CEO, Tempest Therapeutics

CEO, AlloVir

Managing Director, Global Research, BofA Securities

Principal, BGR Group

President, Mass General Hospital; – MGH Trustees Professor of Emergency Medicine, HMS

CEO, MassChallenge

Managing Director, Co-Head, North American Healthcare Investment Banking, Head of Life Sciences Investment Banking, BofA Securities

Commissioner, US Food and Drug Administration

Professor of Radiology, University of Michigan

Senior Vice President and Chief Medical Officer CVS Health

Pathologist and Principal Investigator, BWH; – Associate Professor of Pathology, HMS

President, Massachusetts, Bank of America

Co-Founder & CTO, Mammoth Biosciences

Managing Director, Senior Equity Research Analyst, BofA Securities

Equity Research Associate, BofA Securities

Chief Innovation Officer, Mass General Brigham

Co-CEO, Amylyx Pharmaceuticals

Director, Lupus Program, BWH; – Professor of Medicine, HMS

Chair, Department of Neurology, MGH; – Julieanne Dorn Professor of Neurology, HMS

EVP and Chief Scientific Officer, REGENXBIO

CEO, Acadia Pharmaceuticals

Director, High Risk Skin Cancer Clinic, MGH; – MGH Research Scholar; – Associate Professor, HMS

General Partner, The Engine

Director, Lab of Medical Imaging and Computation, Mass General Brigham; – Assistant Professor, HMS

Surgeon-in-Chief, BWH; – Moseley Professor of Surgery, HMS

Chief Scientific Officer & President, Worldwide Research, Development and Medical, Pfizer

Eaton Peabody Professor of Otolaryngology, HMS, Mass Eye and Ear

Associate Pediatrician, Mass General for Children; – Assistant Professor of Pediatrics, HMS

Principal Investigator, Wellman Center for Photomedicine, MGH; – Associate Professor, HMS

Chair of Psychiatry, MGH; – Slater Family Professor of Psychiatry, HMS

Radiologist, Physician-Scientist, MGH; – Associate Professor of Radiology, HMS

Partner, Mass General Brigham Ventures

Director of Clinical Research, Mass General Cancer Center; – Professor of Medicine, HMS

Partner, Atlas Venture

Vice President, Strategic Innovation Leaders, Mass General Brigham Innovation

SVP, Business Development and Corporate Strategy, Moderna

Founder & General Partner, Mission BioCapital; – Co-Founder & President, LabCentral; – CEO, BioLabs

Chief Financial Officer, Mass General Brigham

Head of US Economics Research, Bank of America

Chief Commercial Officer, Moderna

Physician-Scientist, Wellman Center for Photomedicine, MGH; – Associate Professor of Dermatology, HMS

President & CEO, Anokion

Biopharma Equity Research Analyst, Bank of America

Co-Director of the Institute for Technology in Psychiatry, – President of the Many Brains Project, McLean Hospital; – Associate Professor of Psychiatry, HMS

Founder, CEO & CIO, GordonMD Global Investments

Former Commissioner, Food and Drug Administration (2017-2019)

Chief of Rheumatology, Inflammation, and Immunity, BWH; – Theodore Bevier Bayles Professor of Medicine, HMS

Neurologist, BWH; – Professor of Neurology, HMS

Director, Mass General Cancer Center; – Kurt J. Isselbacher Professor of Oncology, HMS

Director, Gene & Cell Therapy Institute Mass General Brigham

Vice President, Global Research, BofA Securities

Secretary of Economic Development, Commonwealth of Massachusetts

Principal, Health & Digital, Oliver Wyman

President & CEO, Sana Biotechnology

Vice President, Global Research, BofA Securities

Governor of the Commonwealth of Massachusetts

CEO, Affimed

CEO, Third Harmonic Bio

CEO, Boundless Bio

Senior Vice President, Network for Excellence in Health Innovation (NEHI)

Director, Neuroregeneration Research Institute, McLean Hospital; – Professor of Neurology and Neuroscience, HMS

Associate Scientist, Schepens Eye Research Institute of Mass Eye and Ear; – Associate Professor of Ophthalmology, HMS

Investigator, Center for Cancer Research, MGH; – Assistant Professor of Medicine, HMS

CEO & Founder, DICE Therapeutics

CEO, ROME Therapeutics

Founder, President & CEO, Sapience Therapeutics

CEO, Celsius Therapeutics

Operating Partner & Senior Advisor, The Riverside Company

Senior Vice President, Business Development, Amgen

Senior Vice President, Venture, Business Development and Licensing, Mass General Brigham

Co-CEO, Amylyx Pharmaceuticals

President & CEO, Mass General Brigham

President & Managing Partner, F-Prime Capital

Partner, Bain Capital Life Sciences

Director of Translational and Clinical Research, BWH; – Assistant Professor of Anesthesia, HMS

President, The Kraft Group; – Chairman, Board of Trustees, MGH

Director, Evergrande Center for Immunologic Diseases, BWH; – Samuel L. Wasserstrom Professor of Neurology, HMS

Araminta Broch-Healey Endowed Chair in ALS, MGH; – Associate Professor of Neurology, HMS

Chief Information Officer and Senior Vice President, Digital, Mass General Brigham – Associate Professor of Emergency Medicine, HMS

President & CEO, Imunon

Chief of Oncodermatology, BHW; – Vice Chair of Dermatology, Dana-Farber Brigham Cancer Center; – Associate Professor of Dermatology, HMS

SVP, Head of Research, GSK

President & CEO, ADARx Pharmaceuticals

Associate Physician, Department of Rheumatology, Inflammation, and Immunity, BWH; – Associate Professor of Medicine and Biomedical Informatics, HMS

Chief Corporate Development & Strategy Officer, Alnylam

CEO, Merus

President & CEO, Vigil Neuroscience

CEO, Notch Therapeutics

Senior Staff Scientist, BWH; – Professor of Pathology, HMS

Principal Investigator, MGH – Assistant Professor, HMS

Managing Director, Global Research, BofA Securities

Managing Director, Healthcare Investment Banking, BofA Securities

Managing Director, Head of Global Healthcare Investment Banking, BofA Securities

CEO, BioXcel Therapeutics

Chief of Ophthalmology, Mass Eye and Ear and MGH; – Ophthalmologist-in-Chief, BWH; – David Glendenning Cogan Professor of Ophthalmology, HMS

President & CEO, REGENXBIO

CEO, Q32 Bio

Chair & CEO, Bank of America

Managing Director, Co-Head of Origination, Americas Equity Capital Markets, BofA Securities

Director-CEVR, Tufts Medical Center

President, Institute for Clinical and Economic Review; – Lecturer, Department of Population Medicine, HMS

CEO, Nuvalent

Director, Familial Dementia Neuroimaging Lab and Director, Multicultural Alzheimer’s Prevention Program, MGH; – Paul B. and Sandra M. Edgerley MGH Research Scholar; – Associate Professor, HMS

Director, Center for Multiple Myeloma, Mass General Cancer Center; – Professor of Medicine, HMS

Chief Scientific Officer, McLean Hospital; – Professor of Psychiatry, HMS

President & CEO, Cognition Therapeutics

Chief Strategy Officer, BioNTech

Chair & CEO, Eli Lilly and Company

CEO & Co-Founder, QurAlis

Chief Financial Officer, UC Davis Health

Chief Scientific Officer, Verge Genomics

President & CEO, AvenCell Therapeutics

CEO & Co-Founder, Compass Therapeutics

CEO, IGM Biosciences

President & CEO, Lyell

Chief, Reproductive Endocrine Unit, MGH; – Professor of Medicine, HMS

Executive Vice President, Chief Scientific Officer, Intellia Therapeutics

Partner, Venrock

Co-Founder & CEO, Hippocratic AI

Vice President, Strategic Innovation Leaders, Mass General Brigham Innovation

President & CEO, Abata Therapeutics

President & Co-Founder, Moveworks

Associate Chief for Research and Director, Center for Precision Psychiatry, Department of Psychiatry, MGH; – Tepper Family MGH Research Scholar; – Professor of Psychiatry, HMS

Associate Physician, BWH; – Associate Professor of Medicine, HMS

Co-Founder & Senior Advisor, Health Advances

Co-CEO, Thomas H. Lee Partners; – Chairman of the Board, Mass General Brigham

Co-Founder & CEO, Endpoint Health

CEO, Chroma Medicine

Vice President, Global Research, BofA Securities

Executive Director, Mass General Brigham MESH Incubator; – Associate Chair of Innovation & Commercialization, Mass General Brigham Radiology; – Strategic Innovation Leader, Mass General Brigham Innovation

Vice-Chair, Neurology, Director, Genetics and Aging Research Unit, MGH; – Joseph P. and Rose F. Kennedy Professor of Neurology, HMS

Associate Clinical Director for Innovation, Mass General Cancer Center; – Associate Professor of Medicine, HMS

Medical Correspondent, CNN

CEO, LEXEO Therapeutics

CEO, Matchpoint Therapeutics

President & CEO, Biogen

Trustees Endowed Scholar in Anesthesia and Alexander Healey Endowed Chair in ALS, Neurology & Anesthesia, Critical Care and Pain Medicine, MGH; – Associate Professor, HMS

Director, Harvard Study of Adult Development, MGH; – Professor of Psychiatry, HMS

Secretary of Health and Human Services, State of Massachusetts

Director of the Center for Learning Health Systems, BWH; – Professor of the Practice of Psychiatry, HMS

Director, Cardio-Rheumatology Clinic, Associate Physician, Prevention Cardiology and Cardiovascular Imaging, BWH; – Instructor of Medicine, HMS

Director, Advanced Research Projects Agency for Health

Pediatric Endocrinologist, MGH; – Assistant Professor, HMS

President & CEO, Kura Oncology

Vice President, US Biopharmaceutical Equity Research Analyst, BofA Securities

Vice President, Global Research, BofA Securities

Monday, June 12, 2023

  • No events found on this date.

Tuesday, June 13, 2023

  • No events found on this date.

Wednesday, June 14, 2023

  • No events found on this date.

Sponsors